To report the outcome of simultaneous bilateral nephrectomy (SBN) and living donor renal transplantation (LDRT) for Autosomal Dominant Polycystic Kidney Disease (ADPKD) in our center.Methods: retrospective comparative chart review study between ADPKD patients who underwent SBN and LDRT (group A) and ADPKD patient who underwent LDRT only (group B) at our center.Results: From May 2010 to August 2017, 7 patients in group A and 15 patients group B were included. Males represented 86% of both groups. Mean patient age (years) and body mass index (BMI) were 46.4 ± 7.6, 27.2 ± 6.9 vs. 43.1 ± 6.9, 25.6 ± 4.2 in groups A and B, respectively. Most common indications of SBN were abdominal discomfort and pain (100%); surgeons indicated loss of abdominal domain (57%), early satiety (28%) and hematuria (28%). All patients received kidney from living donors. Mean operative time and estimated blood loss were 379.8 ± 24min, 130.7 ± 15 vs. 464 ± 30 ml, 170 ± 10 in groups A and B respectively. Average length of stay(days) was 9.4 ± 1 and 7.8 ± 1.1 in groups A and B respectively. All patients had immediate graft function with average serum creatinine(mmol/l) on discharge, one month and last follow up were 85.6,78.6,81 vs. 77 ± 17,84 ± 12,93 ± 8 in groups A and B, respectively. There was no mortality, rejections, wound complications, collections or reoperation in both groups. One year graft and patient survival in both groups was 100%.
Conclusion:SBN and LDRT is an acceptable alternative to a conventional two stage procedure without added morbidity and without significant negative impact on patient and graft survival, obviating the need for a separate procedure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.